SP: IO meets IO: Current Status and Future Synergistic Opportunities With Interventional Oncology and Immuno-oncology
- Opening and Introduction
: Nutcha Pinjaroen
- Optimal Role of Immunotherapy Combination in Intermediate to Advanced Stage of HCC
: Masatoshi Kudo
- Interesting Case Sharing: How to Achieve Clinical Complete Response by Individaulized Strategy with Cancer Immunotherapy and Conversion Strategy
: Chien-An Liu
- Q&A
Moderator
Nutcha Pinjaroen
Speakers
Chien-An Liu
Masatoshi Kudo
Nutcha Pinjaroen